<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">18889</article-id><article-id pub-id-type="doi">10.7554/eLife.18889</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Advance</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Establishment and stability of the latent HIV-1 DNA reservoir</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-41740"><name><surname>Brodin</surname><given-names>Johanna</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-29952"><name><surname>Zanini</surname><given-names>Fabio</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-41741"><name><surname>Thebo</surname><given-names>Lina</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-4539"><name><surname>Lanz</surname><given-names>Christa</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-41739"><name><surname>Bratt</surname><given-names>Göran</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-1701"><name><surname>Neher</surname><given-names>Richard A</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2525-1407</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-16689"><name><surname>Albert</surname><given-names>Jan</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9020-0521</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Microbiology, Tumor and Cell Biology</institution>, <institution>Karolinska Institute</institution>, <addr-line><named-content content-type="city">Stockholm</named-content></addr-line>, <country>Sweden</country></aff><aff id="aff2"><institution>Stanford University</institution>, <addr-line><named-content content-type="city">Stanford</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution>Max Planck Institute for Developmental Biology</institution>, <addr-line><named-content content-type="city">Tübingen</named-content></addr-line>, <country>Germany</country></aff><aff id="aff4"><institution content-type="dept">Department of Clinical Science and Education, Venhälsan</institution>, <institution>Stockholm South General Hospital</institution>, <addr-line><named-content content-type="city">Stockholm</named-content></addr-line>, <country>Sweden</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-9459"><name><surname>Chakraborty</surname><given-names>Arup K</given-names></name><role>Reviewing editor</role><aff><institution>Massachusetts Institute of Technology</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>Jan.Albert@ki.se</email> (JA);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>15</day><month>11</month><year>2016</year></pub-date><volume>5</volume><elocation-id>e18889</elocation-id><history><date date-type="received"><day>20</day><month>06</month><year>2016</year></date><date date-type="accepted"><day>01</day><month>11</month><year>2016</year></date></history><permissions><copyright-statement>© 2016, Brodin et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Brodin et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-18889-v1.pdf"/><abstract><p>HIV-1 infection cannot be cured because the virus persists as integrated proviral DNA in long-lived cells despite years of suppressive antiretroviral therapy (ART). In a previous paper (Zanini, 2015) we documented HIV-1 evolution 10 untreated patients. Here we characterize establishment, turnover, and evolution of viral DNA reservoirs in the same patients after 3-18 years of suppressive ART. A median of 14\% (range 0-42\%) of the DNA sequences were defective due to G-to-A hypermutation. Remaining DNA sequences showed no evidence of evolution over years of suppressive ART. Most sequences from the DNA reservoirs were very similar to viruses actively replicating in plasma (RNA sequences) shortly before start of ART. The results do not support persistent HIV-1 replication as a mechanism to maintain the HIV-1 reservoir during suppressive therapy. Rather, the data indicate that DNA variants are turning over as long as patients are untreated and that suppressive ART halts this turnover.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Viruses</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000781</institution-id><institution>European Research Council</institution></institution-wrap></funding-source><award-id>Stg. 260686</award-id><principal-award-recipient><name><surname>Neher</surname><given-names>Richard A</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004359</institution-id><institution>Vetenskapsrådet</institution></institution-wrap></funding-source><award-id>K2014-57X-09935</award-id><principal-award-recipient><name><surname>Albert</surname><given-names>Jan</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Richard A Neher, Reviewing editor, eLife.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: The study was conducted according to the Declaration of Helsinki. Ethical approval was granted by the Regional Ethical Review board in Stockholm, Sweden (Dnr 2012/505 and 2014/646). Patients participating in the study gave written and oral informed consent to participate.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="datasets"><title>Major datasets</title><p/><p>The following datasets were generated:</p><p><related-object content-type="generated-dataset" id="dataro1" source-id="http://www.ebi.ac.uk/ena/data/view/PRJEB13841" source-id-type="uri"><collab>Brodin J</collab>, <collab>Zanini F</collab>, <collab>Thebo L</collab>, <collab>Lanz C</collab>, <collab>Bratt G</collab>, <collab>Neher RA</collab>, <collab>Albert J</collab>, <year>2016</year><x>,</x> <source>Establishment and stability of the latent HIV-1 DNA reservoir</source><x>,</x> <ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/ena/data/view/PRJEB13841">http://www.ebi.ac.uk/ena/data/view/PRJEB13841</ext-link><x>,</x> <comment>Publicly available at the EBI European Nucleotide Archive (Accession no: PRJEB13841)</comment></related-object></p><p>The following previously published datasets were used:</p><p><related-object content-type="generated-dataset" id="dataro2" source-id="http://www.ebi.ac.uk/ena/data/search?query=PRJEB9618" source-id-type="uri"><collab>Zanini F</collab>, <collab>Neher R</collab>, <year>2015</year><x>,</x> <source>HIVEVO</source><x>,</x> <ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/ena/data/search?query=PRJEB9618">http://www.ebi.ac.uk/ena/data/search?query=PRJEB9618</ext-link><x>,</x> <comment>Publicly available at the EBI European Nucleotide Archive (Accession no: PRJEB9618)</comment></related-object></p></sec><supplementary-material><ext-link xlink:href="elife-18889-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>